Search
Author
- Jan Cato, Holter (1)
- José R., Arribas (1)
- Kristian, Holm (1)
- Lambert, Assoumou (1)
- next >
Subject
- Bari-SolidAct (1)
- Gut microbiota alterat... (1)
- gut microbiota and mor... (1)
- placebo-controlled pha... (1)
- next >
Date issued
- 2023 (2)
Has File(s)
- true (2)
Search Results
Gut microbiota alterations have been reported in hospitalized COVID-19 patients, with reduced alpha diversity and altered microbiota composition related to respiratory failure. However, data regarding gut microbiota and mortality are scarce. |
Baricitinib has shown efficacy in hospitalized patients with COVID-19, but no placebo-controlled trials have focused specifically on severe/critical COVID, including vaccinated participants. |